↓ Skip to main content

End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain

Overview of attention for article published in Blood Advances, December 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet
twitter
4 X users

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
136 Mendeley
Title
End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain
Published in
Blood Advances, December 2019
DOI 10.1182/bloodadvances.2019000882
Pubmed ID
Authors

Ann T Farrell, Julie Panepinto, C Patrick Carroll, Deepika S Darbari, Ankit A Desai, Allison A King, Robert J Adams, Tabitha D Barber, Amanda M Brandow, Michael R DeBaun, Manus J Donahue, Kalpna Gupta, Jane S Hankins, Michelle Kameka, Fenella J Kirkham, Harvey Luksenburg, Shirley Miller, Patricia Ann Oneal, David C Rees, Rosanna Setse, Vivien A Sheehan, John Strouse, Cheryl L Stucky, Ellen M Werner, John C Wood, William T Zempsky

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 136 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 136 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 11%
Student > Ph. D. Student 11 8%
Student > Bachelor 11 8%
Student > Master 8 6%
Professor 7 5%
Other 27 20%
Unknown 57 42%
Readers by discipline Count As %
Medicine and Dentistry 28 21%
Nursing and Health Professions 10 7%
Psychology 8 6%
Neuroscience 6 4%
Biochemistry, Genetics and Molecular Biology 6 4%
Other 20 15%
Unknown 58 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2024.
All research outputs
#3,095,999
of 25,795,662 outputs
Outputs from Blood Advances
#703
of 3,353 outputs
Outputs of similar age
#70,635
of 479,623 outputs
Outputs of similar age from Blood Advances
#15
of 119 outputs
Altmetric has tracked 25,795,662 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,353 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.3. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 479,623 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 119 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.